Qiagen NV (QGEN)
42.63
-0.60
(-1.39%)
USD |
NYSE |
Nov 13, 16:00
42.64
0.00 (0.00%)
After-Hours: 20:00
Qiagen Price to Book Value: 2.782 for Nov. 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 13, 2024 | 2.782 |
November 12, 2024 | 2.821 |
November 11, 2024 | 2.875 |
November 08, 2024 | 2.856 |
November 07, 2024 | 2.881 |
November 06, 2024 | 2.863 |
November 05, 2024 | 2.868 |
November 04, 2024 | 2.849 |
November 01, 2024 | 2.812 |
October 31, 2024 | 2.748 |
October 30, 2024 | 2.757 |
October 29, 2024 | 2.73 |
October 28, 2024 | 2.728 |
October 25, 2024 | 2.712 |
October 24, 2024 | 2.715 |
October 23, 2024 | 2.749 |
October 22, 2024 | 2.755 |
October 21, 2024 | 2.749 |
October 18, 2024 | 2.806 |
October 17, 2024 | 2.786 |
October 16, 2024 | 2.820 |
October 15, 2024 | 2.864 |
October 14, 2024 | 2.878 |
October 11, 2024 | 2.866 |
October 10, 2024 | 2.825 |
Date | Value |
---|---|
October 09, 2024 | 2.901 |
October 08, 2024 | 2.843 |
October 07, 2024 | 2.827 |
October 04, 2024 | 2.844 |
October 03, 2024 | 2.842 |
October 02, 2024 | 2.894 |
October 01, 2024 | 2.931 |
September 30, 2024 | 2.974 |
September 27, 2024 | 2.953 |
September 26, 2024 | 2.938 |
September 25, 2024 | 2.879 |
September 24, 2024 | 2.928 |
September 23, 2024 | 2.902 |
September 20, 2024 | 2.930 |
September 19, 2024 | 2.975 |
September 18, 2024 | 2.981 |
September 17, 2024 | 2.98 |
September 16, 2024 | 3.039 |
September 13, 2024 | 3.026 |
September 12, 2024 | 2.974 |
September 11, 2024 | 2.992 |
September 10, 2024 | 2.996 |
September 09, 2024 | 2.995 |
September 06, 2024 | 2.903 |
September 05, 2024 | 2.903 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.196
Minimum
Oct 30 2023
4.619
Maximum
Oct 09 2020
3.392
Average
3.296
Median
Price to Book Value Benchmarks
LENZ Therapeutics Inc | 4.649 |
Oruka Therapeutics Inc | -- |
Boston Scientific Corp | 6.318 |
uniQure NV | 5.938 |
ProQR Therapeutics NV | 9.231 |
Price to Book Value Related Metrics
PE Ratio | 134.42 |
PS Ratio | 4.922 |
Price to Free Cash Flow | 23.57 |
Price | 42.63 |
Earnings Yield | 0.74% |
Market Cap | 9.474B |
Operating PE Ratio | 57.33 |
Normalized PE Ratio | 65.06 |